Q1 2022 Holdings
Filed 2022-05-16 | 106 holdings | $891.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medicus Sciences Acquisition | *W EXP 02/12/202 | G5960S124 | $14 | 33,331 | 0.0% |
| Renovacor Inc | *W EXP 99/99/999 | 75989E114 | $109 | 350,000 | 0.0% |
| Zymergen Inc | COM | 98985X100 | $202 | 70,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $293 | 223,725 | 0.0% |
| Singular Genomics Systems in | COM | 82933R100 | $631 | 100,000 | 0.0% |
| Minerva Surgical Inc | COM | 60343F106 | $747 | 166,000 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $760 | 40,000 | 0.0% |
| Akoya Biosciences Inc | COM | 00974H104 | $854 | 77,676 | 0.0% |
| Codex DNA Inc | COM | 192003101 | $1.1K | 200,000 | 0.0% |
| Miromatrix MED Inc | COM | 60471P108 | $1.1K | 280,000 | 0.0% |
| Isoplexis Corp | COM | 465005106 | $1.3K | 365,000 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $1.3K | 446,564 | 0.0% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $1.4K | 199,567 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $1.6K | 258,064 | 0.0% |
| Sophia Genetics SA(SOPH) | ORDINARY SHARES | H82027105 | $1.8K | 226,589 | 0.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $1.9K | 150,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.6K | 51,194 | 0.0% |
| Genetron Hldgs LTD | ADS | 37186H100 | $2.6K | 1,198,961 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $2.8K | 350,000 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $2.9K | 3,250,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $2.9K | 300,000 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $3.2K | 18,127 | 0.0% |
| 5 01 Acquisition Corp | COM CL A | 33836P105 | $3.9K | 392,000 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $3.9K | 490,000 | 0.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $4.0K | 802,717 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $4.8K | 1,100,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $4.9K | 500,000 | 0.0% |
| Summit Healthcre Acquistn Co | UNIT 06/03/2026 | G8566R128 | $4.9K | 500,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $4.9K | 500,000 | 0.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $5.6K | 161,138 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $6.0K | 612,500 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $6.2K | 637,000 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $6.3K | 4,275,722 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $6.4K | 7,019,610 | 0.0% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $6.6K | 344,911 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.5K | 857,464 | 0.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $8.0K | 990,143 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $8.6K | 2,120,760 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $8.8K | 3,582,481 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $9.9K | 2,327,403 | 0.0% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $11.5K | 997,099 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $11.8K | 1,017,546 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $12.7K | 3,000,803 | 0.0% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $14.0K | 1,602,381 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $14.0K | 404,029 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $15.7K | 489,014 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $16.3K | 2,637,192 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $17.0K | 1,214,572 | 0.0% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $18.0K | 1,018,188 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $19.8K | 798,255 | 0.0% |